FDA Inspection
Taro Pharmaceuticals U.S.A., Inc.Taro Pharmaceuticals U.S.A., Inc. – FDA Inspection, May 29, 2009
Record Details
This FDA Inspection record concerns Taro Pharmaceuticals U.S.A., Inc., with an inspection on May 29, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 29, 2009
- Product Type
- Drugs
View Company Profile
ID · b4d8321d-21b9-4670-bce8-c3162fcc256a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 592198
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 314.80(b)Failure to review ADE information
- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
- 21 CFR 314.80(c)(2)Late submission of quarterly safety reports
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Taro Pharmaceuticals U.S.A., Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 27, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 19, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 18, 2013 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| March 8, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Taro Pharmaceuticals U.S.A., Inc.
- FDA Inspection 1066575 - 2018-08-27
- FDA Inspection 907479 - 2014-12-19
- FDA Inspection 827465 - 2013-04-18
- FDA Inspection 769594 - 2012-03-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.